Matches in Nanopublications for { ?s ?p "[FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS) as a consequence of exogenous FSH administration, or with a spontaneous onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_assertion description "[FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS) as a consequence of exogenous FSH administration, or with a spontaneous onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_provenance.
- NP858668.RAdCubgCc8R0XjFTqSHI0hx-SGJ7EgBoz2U3E4Vs2OCLU130_assertion description "[FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS) as a consequence of exogenous FSH administration, or with a spontaneous onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858668.RAdCubgCc8R0XjFTqSHI0hx-SGJ7EgBoz2U3E4Vs2OCLU130_provenance.
- assertion description "[FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS) as a consequence of exogenous FSH administration, or with a spontaneous onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP615959.RAOd1e8ugbQFq-9t9CYoQu_aAhjheP79ybYSXs5rym4yQ130_assertion description "[FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS) as a consequence of exogenous FSH administration, or with a spontaneous onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615959.RAOd1e8ugbQFq-9t9CYoQu_aAhjheP79ybYSXs5rym4yQ130_provenance.
- NP704318.RASFgVw5BkqD2RSMxTGw6gPtoFylyNERqPRBFigGcR7_k130_assertion description "[FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS) as a consequence of exogenous FSH administration, or with a spontaneous onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704318.RASFgVw5BkqD2RSMxTGw6gPtoFylyNERqPRBFigGcR7_k130_provenance.
- NP413147.RAveBxU9tV0_BLRKABSqL5KhNyG4ilh2FXc0Rqm9vb8Ug130_assertion description "[FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS) as a consequence of exogenous FSH administration, or with a spontaneous onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413147.RAveBxU9tV0_BLRKABSqL5KhNyG4ilh2FXc0Rqm9vb8Ug130_provenance.
- NP704321.RAq8LdAicdkNKwxNVC2NKqGPNS25ZdCT5Do-T9Cu0dAF4130_assertion description "[FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS) as a consequence of exogenous FSH administration, or with a spontaneous onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704321.RAq8LdAicdkNKwxNVC2NKqGPNS25ZdCT5Do-T9Cu0dAF4130_provenance.
- NP413174.RAIN9KbnT_qpNUVnATq0TCiy8b0kyWsZEv1aSyHGgzJvo130_assertion description "[FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS) as a consequence of exogenous FSH administration, or with a spontaneous onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413174.RAIN9KbnT_qpNUVnATq0TCiy8b0kyWsZEv1aSyHGgzJvo130_provenance.
- NP704320.RANuJuwFnD31kS9j0h-m0mjAHvSY7PE-H7bNA0fYHqAz8130_assertion description "[FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS) as a consequence of exogenous FSH administration, or with a spontaneous onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704320.RANuJuwFnD31kS9j0h-m0mjAHvSY7PE-H7bNA0fYHqAz8130_provenance.